drug development

Biopharma has abandoned antibiotic development. Here’s why we did, too.
Biopharma has abandoned antibiotic development. Here’s why we did, too.
Endpoints
Octagon Therapeutics
drug discovery
drug development
antibiotics
Flag link:
Omega Funds Closes $438 Million Fund VI Aimed at the Life Sciences
Omega Funds Closes $438 Million Fund VI Aimed at the Life Sciences
BioSpace
Omega Funds
drug development
Flag link:
Elsevier gets FDA backing for ‘predictive toxicology’ project
Elsevier gets FDA backing for ‘predictive toxicology’ project
Pharmaforum
Elsevier
FDA
drug development
predictive toxicology
liver toxicity
Flag link:
Researchers Call on FDA to Rethink Guidance Allowing Use of Surrogate Outcomes
Researchers Call on FDA to Rethink Guidance Allowing Use of Surrogate Outcomes
RAPS.org
FDA
JAMA
infectious diseases
drug development
surrogate endpoints
Flag link:
Researchers ID 10 New Drug Targets for Aggressive Brain Cancer Glioblastoma
Researchers ID 10 New Drug Targets for Aggressive Brain Cancer Glioblastoma
BioSpace
R&D
glioblastoma
drug development
Flag link:
Why Scott Gottlieb, venture capitalist, sees opportunity in antibiotics
Why Scott Gottlieb, venture capitalist, sees opportunity in antibiotics
Endpoints
Scott Gottlieb
FDA
antibiotics
drug development
Flag link:
Biogen Alzheimer's Case Shows Danger of Trials Killing Good Drugs
Biogen Alzheimer's Case Shows Danger of Trials Killing Good Drugs
Yahoo/Guru Focus
Biogen
Alzheimer's disease
aducanumab
clinical trials
drug development
Flag link:
How influenza discoveries could inspire a universal vaccine and new treatments
How influenza discoveries could inspire a universal vaccine and new treatments
Fierce Biotech
drug discovery
infuenza
antivirals
drug development
vaccines
Flag link:
Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie
Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie
BioSpace
AbbVie
cystic fibrosis
drug development
Flag link:
Public funds help late-stage development of about 25% of new drugs, study finds
Public funds help late-stage development of about 25% of new drugs, study finds
Endpoints
drug development
public funding
Flag link:
Still too little progress on antibiotic resistance, says O’Neill report update
Still too little progress on antibiotic resistance, says O’Neill report update
Pharmaforum
antibiotics
antibiotic resistance
drug development
Flag link:
Distorted Drug Patents: Does the U.S. Legal System Steer Researchers Away From Drugs that Take a Long Time to Develop?
Distorted Drug Patents: Does the U.S. Legal System Steer Researchers Away From Drugs that Take a Long Time to Develop?
FDA Law Blog
patents
innovation
drug development
FDA
Flag link:
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Globe Newswire
Novartis
Microsoft
artificial intelligence
innovation
drug development
Flag link:
Patient-focused drug development: New FDA draft guidance delves into what’s important
Patient-focused drug development: New FDA draft guidance delves into what’s important
Endpoints
FDA
drug development
patients
Flag link:
Researchers Develop New Class of Lung Cancer Drugs
Researchers Develop New Class of Lung Cancer Drugs
BioSpace
lung cancer
KRAS inhibitors
Institute of Cancer Research
drug development
Flag link:
In U.S. Biosimilars Run Into More Roadblocks
In U.S. Biosimilars Run Into More Roadblocks
Forbes
biosimilars
drug development
Flag link:
Citing phase 2 figures, Axon looks for big pharma investment for Alzheimer’s vaccine
Citing phase 2 figures, Axon looks for big pharma investment for Alzheimer’s vaccine
Pharmaforum
Alzheimer's disease
drug development
vaccines
Axon
Flag link:
New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer's, addiction and more
New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer's, addiction and more
Fierce Biotech
psychedelic drugs
Johns Hopkins
drug development
Alzheimer's disease
addiction
Flag link:
FDA's new guidance on heart failure could change the way we treat patients and develop drugs
FDA's new guidance on heart failure could change the way we treat patients and develop drugs
The Hill
FDA
heart failure
drug development
Flag link:
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight
Xconomy
Celgene
cell therapies
drug development
Immatics
cancer
Flag link:

Pages